Michael D. Gillett

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

R. Houston Thompson, Michael D. Gillett, John C. Cheville et al. · Proceedings of the National Academy of Sciences · 2004 · 766 citations · Full text

Medicine, Immunology, Oncology +17

618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target

R. Houston Thompson, Michael D. Gillett, John C. Cheville et al. · The Journal of Urology · 2005 · 387 citations · Full text

Medicine, Cancer Biology, Oncology +13

Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinoma

R. Houston Thompson, Michael D. Gillett, John C. Cheville et al. · Cancer · 2005 · 173 citations

Medicine, Immunology, Oncology +17

COMPARISON OF PRESENTATION AND OUTCOME FOR PATIENTS 18 TO 40 AND 60 TO 70 YEARS OLD WITH SOLID RENAL MASSES

Michael D. Gillett, John C. Cheville, R. Jeffrey Karnes et al. · The Journal of Urology · 2005 · 94 citations

Medicine, Oncology, Pathology +17

Differences in Organ System of Distant Metastasis by Renal Cell Carcinoma Subtype

Nathan E. Hoffmann, Michael D. Gillett, John C. Cheville et al. · The Journal of Urology · 2008 · 91 citations

Medicine, Oncology, Surgery +13